277 related articles for article (PubMed ID: 26852750)
1. miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1.
Zhan M; Zhao X; Wang H; Chen W; Xu S; Wang W; Shen H; Huang S; Wang J
Tumour Biol; 2016 Aug; 37(8):10553-62. PubMed ID: 26852750
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
Wu DD; Li XS; Meng XN; Yan J; Zong ZH
Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
[TBL] [Abstract][Full Text] [Related]
3. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation.
Wang H; Li X; Chen T; Wang W; Liu Q; Li H; Yi J; Wang J
Oncol Rep; 2013 Feb; 29(2):676-84. PubMed ID: 23229154
[TBL] [Abstract][Full Text] [Related]
5. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
[TBL] [Abstract][Full Text] [Related]
6. miR-634 Activates the Mitochondrial Apoptosis Pathway and Enhances Chemotherapy-Induced Cytotoxicity.
Fujiwara N; Inoue J; Kawano T; Tanimoto K; Kozaki K; Inazawa J
Cancer Res; 2015 Sep; 75(18):3890-901. PubMed ID: 26216549
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
8. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
[TBL] [Abstract][Full Text] [Related]
9. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression.
Zhang X; Zhang L; Chen M; Liu D
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):315-324. PubMed ID: 31858815
[TBL] [Abstract][Full Text] [Related]
10. LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma.
He Y; Chen X; Yu Y; Li J; Hu Q; Xue C; Chen J; Shen S; Luo Y; Ren F; Li C; Bao J; Yan J; Qian G; Ren Z; Sun R; Cui G
Mol Carcinog; 2018 Jun; 57(6):772-783. PubMed ID: 29569755
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
[TBL] [Abstract][Full Text] [Related]
12. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y
Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078
[TBL] [Abstract][Full Text] [Related]
13. MiR-20a triggers metastasis of gallbladder carcinoma.
Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
[TBL] [Abstract][Full Text] [Related]
14. MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B.
Xiao F; Li Y; Wan Y; Xue M
Cancer Chemother Pharmacol; 2018 May; 81(5):935-947. PubMed ID: 29594361
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
Zhou N; Cheng W; Peng C; Liu Y; Jiang B
Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
[TBL] [Abstract][Full Text] [Related]
17. miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.
Wang H; Zhan M; Xu SW; Chen W; Long MM; Shi YH; Liu Q; Mohan M; Wang J
Cell Death Dis; 2017 May; 8(5):e2770. PubMed ID: 28492560
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA aberrations: An emerging field for gallbladder cancer management.
Chandra V; Kim JJ; Mittal B; Rai R
World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
[TBL] [Abstract][Full Text] [Related]
19. miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer.
Yang D; Zhan M; Chen T; Chen W; Zhang Y; Xu S; Yan J; Huang Q; Wang J
Sci Rep; 2017 Mar; 7():43109. PubMed ID: 28256505
[TBL] [Abstract][Full Text] [Related]
20. Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma.
Lv YP; Shi W; Liu HX; Kong XJ; Dai DL
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):518-522. PubMed ID: 28239818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
